1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 3,220 | 3,340 | 13:04 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.03. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2024 | 2 | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 11.03. | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | - | HKEx | ||
| 04.03. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 19.02. | HAOHAI BIOTEC (06826): ANNOUNCEMENT OF PRELIMINARY ANNUAL RESULTS FOR THE YEAR 2024 | - | HKEx | ||
| 16.01. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 08.01. | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 27.12.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 17.12.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 29.11.24 | HAOHAI BIOTEC (06826): ANNOUNCEMENT IN RELATION TO ADJUSTMENTS TO THE NUMBER OF RESTRICTED SHARES AND THE GRANT PRICE UNDER THE 2021 RESTRICTED A SHARE ... | - | HKEx | ||
| 28.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 21.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 3 | HKEx | ||
| 13.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 05.11.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 28.10.24 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 25.10.24 | HAOHAI BIOTEC (06826): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | 2 | HKEx | ||
| 25.10.24 | HAOHAI BIOTEC (06826): WORKING RULES OF THE STRATEGY AND SUSTAINABLE DEVELOPMENT COMMITTEE OF THE BOARD | 1 | HKEx | ||
| 25.10.24 | HAOHAI BIOTEC (06826): WORKING RULES OF THE AUDIT COMMITTEE OF THE BOARD | - | HKEx | ||
| 25.10.24 | HAOHAI BIOTEC (06826): 2024 THIRD QUARTERLY REPORT; AMENDMENTS TO THE WORKING RULES OF THE STRATEGY COMMITTEE AND THE AUDIT COMMITTEE; AND CHANGE OF NAME ... | 3 | HKEx | ||
| 15.10.24 | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | - | HKEx |
Seite:
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 3,270 | -0,49 % | Valneva liefert Chikungunya-Impfstoff nach La Réunion | Valneva liefert ab Anfang April 40.000 Dosen des Chikungunya-Impfstoffs IXCHIQ nach La Réunion. Damit reagiert das französische Unternehmen auf einen Regierungsappell im Zuge des starken Ausbruchs auf... ► Artikel lesen | |
| AMGEN | 283,45 | +0,50 % | Which Dow Jones Stock Is Cheaper, Amgen or Merck? | ||
| STRYKER | 337,00 | +0,12 % | US-Militär verstärkt Grenzsicherung mit Stryker-Fahrzeugen | ||
| REGENERON PHARMACEUTICALS | 592,00 | +0,68 % | Regeneron Pharmaceuticals (NASDAQ:REGN) Hits New 12-Month Low - What's Next? | ||
| EXACT SCIENCES | 40,340 | +0,06 % | Benchmark maintains Buy on Exact Sciences, price target at $65 | ||
| CSL | 143,80 | +0,38 % | CSL shares haven't been this cheap in 9 years: Time to buy? | ||
| CANSINO BIOLOGICS | 3,960 | -1,00 % | CanSino Biologics Inc: Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong | HONG KONG, Mar 25, 2025 - (ACN Newswire) - CanSino Biologics Inc. (Stock Code: 688185.SH, 6185.HK, 'CanSinoBIO' or the 'Company'), a leading player in China's vaccine industry, achieved significant... ► Artikel lesen | |
| BEIGENE LTD ADR | 250,00 | +0,81 % | BEIGENE (06160): ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2024 | ||
| BIOMERIEUX | 116,50 | +0,17 % | BIOMERIEUX: Release of the Universal Registration Document including the Annual Financial Report as of December 31, 2024 | ||
| SINO BIOPHARM | 0,428 | -0,16 % | Kurs von Sino Biopharmaceutical steigt etwas (0,4449 €) | Am Aktienmarkt liegt die Aktie von Sino Biopharmaceutical derzeit im Plus. Zuletzt zahlten Investoren für das Papier 0,44 Euro. Eine Verteuerung in Höhe von 1 Cent erfreut derzeit die Aktionäre von... ► Artikel lesen | |
| ZAI LAB LTD ADR | 34,600 | +0,58 % | HSI Closes Midday at 23,368, Down 210 pts; HSTI Closes Midday at 5,495, Down 93 pts; HAIER SMARTHOME Down over 7%; HANSOH PHARMA, ZAI LAB, CHINA EAST EDU, 3SBIO, CRYSTAL INTL Hit New Highs | ||
| CSTONE PHARMACEUTICALS | 0,392 | -3,92 % | CStone Pharmaceuticals Announces 2024 Annual Results and Recent Business Progress | Financial Performance: Strong Year-over-Year Improvement- Total Revenue: RMB 407.2 million, including RMB 232.1 million in licensing and royalty income.- ... ► Artikel lesen | |
| CASI PHARMACEUTICALS | 2,190 | 0,00 % | CASI Pharmaceuticals: CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia | BEIJING, CHINA / ACCESSWIRE / January 6, 2025 / CASI Pharmaceuticals, Inc. (Nasdaq:CASI), a biopharmaceutical company specializing in the development and commercialization of innovative therapeutic... ► Artikel lesen | |
| 3SBIO | 1,430 | 0,00 % | CMBI: 3SBIO's Earnings Beat; Product Line Expansion Ensures Future Growth | ||
| GENSCRIPT BIOTECH | 1,480 | +0,68 % | GenScript Biotech Corporation Reports FY 2024 Results | Strategic deconsolidation of Legend Biotech unlocked significant value, while core businesses experienced rapid growth.
PISCATAWAY, N.J., March 12, 2025 /PRNewswire/... ► Artikel lesen |
SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD gehört der Branche Biotechnologie an. Mit einer aktuellen Kursveränderung von -0,020 (-0,61 %) liegt der Kurs bei 3,240 Euro. Aus der Ausschüttung der letzten 12 Monate von insgesamt 0,00 Euro errechnet sich eine Dividendendrendite von 0,00 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD finden Sie auf Wallstreet Online.
